
Redox Biology, Journal Year: 2024, Volume and Issue: 79, P. 103465 - 103465
Published: Dec. 13, 2024
Language: Английский
Redox Biology, Journal Year: 2024, Volume and Issue: 79, P. 103465 - 103465
Published: Dec. 13, 2024
Language: Английский
Frontiers in Cardiovascular Medicine, Journal Year: 2025, Volume and Issue: 12
Published: April 25, 2025
Atherosclerosis (AS), a chronic inflammatory disease, remains leading contributor to cardiovascular morbidity and mortality. Recent studies highlight the critical role of cGAS-STING pathway—a key innate immune signaling cascade—in driving AS progression. This pathway is activated by cytoplasmic DNA from damaged cells, thereby triggering inflammation accelerating plaque formation. While risk factors such as aging, obesity, smoking, hypertension, diabetes are known exacerbate AS, emerging evidence suggests that these may also enhance pathway, which amplifies responses. Targeting this offers promising therapeutic strategy reduce burden diseases (CVD). In review, we summarize mechanisms explore its in evaluate potential inhibitors future candidates. By integrating current knowledge, aim provide insights for developing novel treatments mitigate CVD burden.
Language: Английский
Citations
0International Immunopharmacology, Journal Year: 2024, Volume and Issue: 133, P. 112114 - 112114
Published: April 22, 2024
Language: Английский
Citations
2Mitochondrion, Journal Year: 2024, Volume and Issue: 76, P. 101886 - 101886
Published: April 24, 2024
Language: Английский
Citations
2Experimental Neurology, Journal Year: 2024, Volume and Issue: 382, P. 114987 - 114987
Published: Oct. 5, 2024
Language: Английский
Citations
2Redox Biology, Journal Year: 2024, Volume and Issue: 79, P. 103465 - 103465
Published: Dec. 13, 2024
Language: Английский
Citations
2